{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:52:49Z","timestamp":1790614369311,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002081","name":"Irish Research Council","doi-asserted-by":"crossref","award":["1010-01"],"award-info":[{"award-number":["1010-01"]}],"id":[{"id":"10.13039\/501100002081","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland (SFI)","doi-asserted-by":"crossref","award":["12\/IA\/1421"],"award-info":[{"award-number":["12\/IA\/1421"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"crossref"}]},{"name":"SFI Research Centre, Advanced Materials and BioEngineering Research (AMBER)","award":["SFI\/12\/RC\/2278"],"award-info":[{"award-number":["SFI\/12\/RC\/2278"]}]},{"name":"European Union FP7","award":["FP7-SME-2012-1"],"award-info":[{"award-number":["FP7-SME-2012-1"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.jconrel.2016.05.001","type":"journal-article","created":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T20:19:36Z","timestamp":1462479576000},"page":"162-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["A novel adjuvanted capsule based strategy for oral vaccination against infectious diarrhoeal pathogens"],"prefix":"10.1016","volume":"233","author":[{"given":"Christopher J.H.","family":"Davitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edel A.","family":"McNeela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Longet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Tobias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3618-5337","authenticated-orcid":false,"given":"Vincenzo","family":"Aversa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig P.","family":"McEntee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan S.","family":"Coulter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Holmgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3167-1080","authenticated-orcid":false,"given":"Ed C.","family":"Lavelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2016.05.001_bb0005","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/01.mcg.0000177231.13770.07","article-title":"Infectious diarrhea in developed and developing countries","volume":"39","author":"Cheng","year":"2005","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0010","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.vaccine.2014.11.048","article-title":"Recommendations regarding the development of combined enterotoxigenic Escherichia coli and Shigella vaccines for infants","volume":"33","author":"Walker","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.05.001_bb0015","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1172\/JCI34005","article-title":"Enteric infections, diarrhea, and their impact on function and development","volume":"118","author":"Petri","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0020","doi-asserted-by":"crossref","first-page":"e72788","DOI":"10.1371\/journal.pone.0072788","article-title":"Global causes of diarrheal disease mortality in childrent 5years of age: a systematic review","volume":"8","author":"Lanata","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2016.05.001_bb0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ecoenv.2015.09.040","article-title":"Seasonal distribution and prevalence of diarrheagenic Escherichia coli in different aquatic environments in Taiwan","volume":"124","author":"Huang","year":"2016","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","article-title":"Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case\u2013control study","volume":"382","author":"Kotloff","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2016.05.001_bb0035","first-page":"63","article-title":"Enterotoxigenic Escherichia coli diarrhea of travelers: a prospective study of American Peace Corps volunteers","volume":"141","author":"Sack","year":"1977","journal-title":"Johns Hopkins Med. J."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0040","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-230X-13-46","article-title":"Pathogen-specific risk of chronic gastrointestinal disorders following bacterial causes of foodborne illness","volume":"13","author":"Porter","year":"2013","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0045","doi-asserted-by":"crossref","first-page":"452","DOI":"10.7205\/MILMED-D-12-00510","article-title":"Quantifying the incidence and burden of postinfectious enteric sequelae","volume":"178","author":"Porter","year":"2013","journal-title":"Mil. Med."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0050","series-title":"The Case for Investment in Enterotoxigenic Escherichia coli Vaccines","author":"PATH","year":"2011"},{"key":"10.1016\/j.jconrel.2016.05.001_bb0055","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/0966-842X(96)10068-8","article-title":"Colonization factors of human enterotoxigenic Escherichia coli (ETEC)","volume":"4","author":"Gaastra","year":"1996","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0060","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/nrmicro2265","article-title":"Molecular mechanisms of Escherichia coli pathogenicity","volume":"8","author":"Croxen","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0065","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1128\/IAI.56.2.523-528.1988","article-title":"Role of PCF8775 antigen and its coli surface subcomponents for colonization, disease, and protective immunogenicity of enterotoxigenic Escherichia coli in rabbits","volume":"56","author":"Svennerholm","year":"1988","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0070","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1128\/IAI.00459-07","article-title":"Disease burden due to enterotoxigenic Escherichia coli in the first 2years of life in an urban community in Bangladesh","volume":"75","author":"Qadri","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0075","first-page":"229","article-title":"Report of the 1966\u201367 cholera vaccine trial in rural East Pakistan","volume":"47","author":"Mosley","year":"1972","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0080","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and the challenge","volume":"6","author":"Neutra","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0085","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1128\/IAI.55.5.1116-1120.1987","article-title":"Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin","volume":"55","author":"Black","year":"1987","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0090","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/INF.0b013e3181fefa1f","article-title":"Real-world impact of rotavirus vaccination","volume":"30","author":"Patel","year":"2011","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0095","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1586\/14760584.7.6.795","article-title":"Vaccines against enterotoxigenic Escherichia coli","volume":"7","author":"Svennerholm","year":"2008","journal-title":"Expert Rev. Vaccines"},{"issue":"Suppl. 3","key":"10.1016\/j.jconrel.2016.05.001_bb0100","doi-asserted-by":"crossref","first-page":"S723","DOI":"10.1097\/00005176-200406003-00003","article-title":"Anatomical and cellular basis of immunity and tolerance in the intestine","volume":"39","author":"Mowat","year":"2004","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0105","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1086\/314543","article-title":"Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group","volume":"179","author":"Savarino","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0110","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.vaccine.2007.12.009","article-title":"Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae","volume":"26","author":"Tobias","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.05.001_bb0115","doi-asserted-by":"crossref","first-page":"6167","DOI":"10.1016\/j.vaccine.2011.06.084","article-title":"A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression","volume":"29","author":"Isidean","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.05.001_bb0120","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/j.vaccine.2013.03.027","volume":"31","author":"Holmgren","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.05.001_bb0125","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.vaccine.2012.12.063","article-title":"Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA\/I overexpressing bacteria and recombinantly produced LTB\/CTB hybrid protein","volume":"31","author":"Lundgren","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.05.001_bb0130","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.addr.2015.03.007","article-title":"Delivery strategies to enhance oral vaccination against enteric infections","volume":"91","author":"Davitt","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0135","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nri3738","article-title":"Regional specialization within the intestinal immune system","volume":"14","author":"Mowat","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-bioeng-071811-150054","article-title":"Mucosal vaccine design and delivery","volume":"14","author":"Woodrow","year":"2012","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0145","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0264-410X(02)00613-8","article-title":"Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen","volume":"21","author":"Katz","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.05.001_bb0150","first-page":"1","article-title":"Enhanced colonic delivery of ciclosporin A self-emulsifying drug delivery system encapsulated in coated minispheres","author":"Keohane","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0155","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jconrel.2015.09.022","article-title":"Targeted delivery of the hydroxylase inhibitor DMOG provides enhanced efficacy with reduced systemic exposure in a murine model of colitis","volume":"217","author":"Tambuwala","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.05.001_bb0160","series-title":"Formulations","author":"Coulter","year":"2014"},{"key":"10.1016\/j.jconrel.2016.05.001_bb0165","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0923-2494(97)80867-X","article-title":"\u201cPERFEXT\u201d: a direct method for quantitative assessment of cytokine production in vivo at the local level","volume":"148","author":"Villavedra","year":"1997","journal-title":"Res. Immunol."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0170","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/B:PHAM.0000016235.32639.23","article-title":"Solubilizing excipients in oral and injectable formulations","volume":"21","author":"Strickley","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0175","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/02652048.2013.808278","article-title":"Repeated dose toxicity study of Vibrio cholerae-loaded gastro-resistant microparticles","volume":"31","author":"Lopez","year":"2014","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0180","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-065X.2010.00970.x","article-title":"Immunology of gut mucosal vaccines","volume":"239","author":"Pasetti","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0185","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: potential and limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0190","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1615\/CritRevImmunol.v15.i3-4.70","article-title":"The mucosal adjuvant activities of ADP-ribosylating bacterial enterotoxins","volume":"15","author":"Snider","year":"1995","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0195","doi-asserted-by":"crossref","first-page":"7077","DOI":"10.1016\/j.vaccine.2014.10.069","article-title":"Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study","volume":"32","author":"Lundgren","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.05.001_bb0200","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bcp.2014.08.017","article-title":"Harnessing the antibacterial and immunological properties of mucosal-associated invariant T cells in the development of novel oral vaccines against enteric infections","volume":"92","author":"Abautret-Daly","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0205","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.coi.2010.04.003","article-title":"Synthetic iNKT cell-agonists as vaccine adjuvants\u2014finding the balance","volume":"22","author":"Cerundolo","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0210","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2217\/imt.13.175","article-title":"Optimizing NKT cell ligands as vaccine adjuvants","volume":"6","author":"Carreno","year":"2014","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jconrel.2016.05.001_bb0215","doi-asserted-by":"crossref","first-page":"6784","DOI":"10.1016\/j.vaccine.2008.10.011","article-title":"Murine antibody responses following systemic or mucosal immunization with viable or inactivated Vibrio cholerae","volume":"26","author":"Nygren","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.05.001_bb0220","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3488","article-title":"Applications of nanotechnology for immunology","volume":"13","author":"Smith","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0225","doi-asserted-by":"crossref","first-page":"8880","DOI":"10.1128\/JVI.00894-06","article-title":"Vaginal protection and immunity after oral immunization of mice with a novel vaccine strain of Listeria monocytogenes expressing human immunodeficiency virus type 1 gag","volume":"80","author":"Zhao","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0230","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/BF00415514","article-title":"Enteric immunization reveals a T cell network for IgA responses and suggests that humans possess a common mucosal immune system","volume":"53","author":"McGhee","year":"1987","journal-title":"Antonie Van Leeuwenhoek"},{"key":"10.1016\/j.jconrel.2016.05.001_bb0235","doi-asserted-by":"crossref","DOI":"10.1038\/mi.2015.107","article-title":"Salivary IgA from the sublingual compartment as a novel noninvasive proxy for intestinal immune induction","author":"Aase","year":"2015","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0240","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1128\/JCM.24.2.203-209.1986","article-title":"Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease","volume":"24","author":"Jertborn","year":"1986","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0245","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1128\/IAI.66.7.3311-3316.1998","article-title":"Intestinal immune responses to an inactivated oral enterotoxigenic Escherichia coli vaccine and associated immunoglobulin A responses in blood","volume":"66","author":"Ahren","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0250","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1172\/JCI17244","article-title":"CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells","volume":"111","author":"Kunkel","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0255","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1182\/blood-2008-04-153544","article-title":"Blood-borne human plasma cells in steady state are derived from mucosal immune responses","volume":"113","author":"Mei","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2016.05.001_bb0260","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1128\/AEM.71.8.4645-4654.2005","article-title":"Critical factors influencing the occurrence of Vibrio cholerae in the environment of Bangladesh","volume":"71","author":"Huq","year":"2005","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0265","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/1471-2458-12-220","article-title":"Diarrhea incidence in low- and middle-income countries in 1990 and 2010: a systematic review","volume":"12","author":"Fischer Walker","year":"2012","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jconrel.2016.05.001_bb0270","first-page":"142","article-title":"Identification and antimicrobial resistance prevalence of pathogenic Escherichia coli strains from treated wastewater effluents in Eastern Cape","volume":"5","author":"Adefisoye","year":"2016","journal-title":"South Africa, Microbiologyopen"},{"key":"10.1016\/j.jconrel.2016.05.001_bb0275","first-page":"188","article-title":"From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development","volume":"133","author":"Svennerholm","year":"2011","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.jconrel.2016.05.001_bb0280","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1007\/s00253-012-3930-6","article-title":"Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates","volume":"93","author":"Tobias","year":"2012","journal-title":"Appl. Microbiol. Biotechnol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916302541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916302541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T13:11:40Z","timestamp":1600521100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365916302541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":56,"alternative-id":["S0168365916302541"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.05.001","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel adjuvanted capsule based strategy for oral vaccination against infectious diarrhoeal pathogens","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}